美国 · 股市与财经 · Investor's Business Daily
Nektar Therapeutics Tumbles Despite Long-Term Benefit From Alopecia Drug
Nektar stock took a hit Thursday despite test results that suggested its drug has long-term benefits for alopecia patients.
在 Investor's Business Daily 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)
